• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体两性霉素B治疗内脏利什曼病的早期疗效

Early efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis.

作者信息

Castagnola E, Davidson R N, Fiore P, Tasso L, Rossi G, Mangraviti S, Di Martino L, Scotti S, Cascio A, Pempinello R, Gradoni L, Giacchino R

机构信息

Department of Infectious Diseases, Gaslini Children's Hospital, Genoa, Italy.

出版信息

Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):317-8. doi: 10.1016/s0035-9203(96)90270-9.

DOI:10.1016/s0035-9203(96)90270-9
PMID:8758092
Abstract

The rapidity and efficacy of a short course of liposomal amphotericin B was evaluated in 29 children affected by visceral leishmaniasis (Leishmania infantum). Their overall health status was assessed using the prognostic inflammatory and nutritional index (PINI), and their haematological status by the reticulocyte count and haemoglobin blood levels. All these quantities were measured on day 0, and 3 and 10 d after starting therapy. A significant decrease of inflammatory signs, associated with an improved reticulocyte count, was recorded after 3 d of therapy. A significant increase of haemoglobin levels was also observed 10 d after the start of treatment. The early reduction of inflammatory signs and the improvement of bone marrow function in most patients confirmed the validity of amphotericin B therapy. The PINI score is helpful in assessing the severity of visceral leishmaniasis and the follow-up of its treatment.

摘要

对29名患内脏利什曼病(婴儿利什曼原虫)的儿童评估了短疗程脂质体两性霉素B的快速性和疗效。使用预后炎症和营养指数(PINI)评估他们的整体健康状况,通过网织红细胞计数和血红蛋白血水平评估他们的血液学状况。所有这些量均在第0天以及开始治疗后3天和10天进行测量。治疗3天后,记录到炎症体征显著减轻,同时网织红细胞计数有所改善。治疗开始10天后还观察到血红蛋白水平显著升高。大多数患者炎症体征的早期减轻和骨髓功能的改善证实了两性霉素B治疗的有效性。PINI评分有助于评估内脏利什曼病的严重程度及其治疗的随访情况。

相似文献

1
Early efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis.脂质体两性霉素B治疗内脏利什曼病的早期疗效
Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):317-8. doi: 10.1016/s0035-9203(96)90270-9.
2
Treatment of visceral leishmaniasis in children with liposomal amphotericin B.脂质体两性霉素B治疗儿童内脏利什曼病
J Pediatr. 1997 Aug;131(2):271-7. doi: 10.1016/s0022-3476(97)70165-3.
3
A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience.脂质体两性霉素B治疗婴幼儿内脏利什曼病的6天疗程:意大利的经验
J Antimicrob Chemother. 2004 Jul;54(1):217-20. doi: 10.1093/jac/dkh279. Epub 2004 May 18.
4
Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B.婴儿利什曼原虫引起的内脏利什曼病所致急性肾衰竭经单次高剂量脂质体两性霉素B成功治愈。
J Travel Med. 2008 Sep-Oct;15(5):358-60. doi: 10.1111/j.1708-8305.2008.00220.x.
5
Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?儿童内脏利什曼病的治疗:两性霉素B还是五价锑化合物?
Int J Antimicrob Agents. 2005 Jan;25(1):26-30. doi: 10.1016/j.ijantimicag.2004.09.011.
6
Successful treatment of visceral leishmaniasis with liposomal amphotericin B.脂质体两性霉素B成功治疗内脏利什曼病。
Acta Biomed. 2006;77 Suppl 2:22-5.
7
[Visceral leishmaniasis in two children after vacation in Southern Europe].[两名儿童在南欧度假后感染内脏利什曼病]
Ugeskr Laeger. 2013 Sep 16;175(38):2193-4.
8
U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.美国食品药品监督管理局批准安必素(两性霉素B脂质体)用于治疗内脏利什曼病。
Clin Infect Dis. 1999 Jan;28(1):49-51. doi: 10.1086/515086.
9
[First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].[法国南部儿童内脏利什曼病的一线脂质体两性霉素B治疗]
Arch Pediatr. 2005 Jul;12(7):1102-8. doi: 10.1016/j.arcped.2005.01.009.
10
Visceral leishmaniasis treated with liposomal amphotericin B.用脂质体两性霉素B治疗内脏利什曼病。
Pediatr Infect Dis J. 1999 Jan;18(1):73-4. doi: 10.1097/00006454-199901000-00021.

引用本文的文献

1
Prevalence, severity, and pathogeneses of anemia in visceral leishmaniasis.内脏利什曼病中贫血的患病率、严重程度及发病机制
Parasitol Res. 2017 Feb;116(2):457-464. doi: 10.1007/s00436-016-5313-x. Epub 2016 Nov 7.
2
Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis.KY62对亚马逊利什曼原虫和杜氏利什曼原虫在实验性小鼠皮肤利什曼病和内脏利什曼病中的疗效。
Antimicrob Agents Chemother. 1998 Oct;42(10):2542-8. doi: 10.1128/AAC.42.10.2542.